[go: up one dir, main page]

Holla et al., 2002 - Google Patents

Rationalizing the Use of Red Cell Tranfusions in the Neonatal Intensive Care Unit

Holla et al., 2002

Document ID
18357572704460272708
Author
Holla R
Mondkar J
Fernandez A
Publication year
Publication venue
Journal of Neonatology

External Links

Snippet

Neonatal intensive care has seen spectacular changes in the past few decades. The availability of surfactant, advanced ventilation techniques, impeccable monitoring systems and a better understanding of neonatal physiology, have made it possible to save the …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0429—Red blood cells; Erythrocytes
    • A61M2202/0437—Blood stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Simon et al. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists
Shannon et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study
Strauss Transfusion therapy in neonates
Bifano et al. Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects
Aher et al. Neonatal anemia
US4695460A (en) Synthetic, plasma-free, transfusible platelet storage medium
EP0313808A2 (en) Synthetic, plasma-free, transfusible storage medium for red blood cells
Crowley et al. A rational approach to red blood cell transfusion in the neonatal ICU
Widness Pathophysiology, diagnosis, and prevention of neonatal anemia
Goodstein et al. Comparison of two preservation solutions for erythrocyte transfusions in newborn infants
Luban Neonatal red blood cell transfusions.
Ballin et al. Vitamin C-induced erythrocyte damage in premature infants
Bader et al. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity
Horn et al. Storage‐induced changes in human newborn red cells
Hume et al. Small volume red blood cell transfusions for neonatal patients
Strauss Blood banking issues pertaining to neonatal red blood cell transfusions
Holla et al. Rationalizing the Use of Red Cell Tranfusions in the Neonatal Intensive Care Unit
Pierson et al. The effect of buffered and non-buffered ACD blood on electrolyte and acid-base homeostasis during exchange transfusion
Valeri et al. Biochemical modification and freeze-preservation of red blood cells: a new method
Luban Review of neonatal red cell transfusion practices
Strauss Blood component transfusions for infants
Valeri et al. Red cell 2, 3 DPG, ATP, and creatine levels in preserved red cells and in patients with red cell mass deficits or with cardiopulmonary insufficiency
CN109675021B (en) Human erythrocyte substitute reconstructed in vitro and its preparation method
CHENNAI " IMPACT OF MATERNAL ANAEMIA ON CORD BLOOD HAEMOGLOBIN
JP2971475B2 (en) Synthetic, plasma-free transfusable storage medium for red blood cells and platelets